Characterisation of a natural variant of the γ-butyrolactone signalling receptor
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterisation of a natural variant of the γ-butyrolactone signalling receptor ; volume:5 ; number:1 ; day:27 ; month:7 ; year:2012 ; pages:1-17 ; date:12.2012
BMC Research Notes / Biomed Central; 5, Heft 1 (27.7.2012), 1-17, 12.2012
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
Gottelt, Marco
Hesketh, Andrew
Bunet, Robert
Puri, Pranav
Takano, Eriko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-0500-5-379
- URN
-
urn:nbn:de:101:1-2019062720330409036902
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gottelt, Marco
- Hesketh, Andrew
- Bunet, Robert
- Puri, Pranav
- Takano, Eriko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling
Abiotic stress : screening and characterisation of signalling mutants
A secreted splice variant of the Xenopus frizzled-4 receptor is a biphasic modulator of Wnt signalling
Structural characterisation of the mammalian SRP receptor
Structural characterisation of peroxisomal import receptor complexes
Role of arylhydrocarbon receptor signalling in reactive gliosis
The signalling conformation of the insulin receptor ectodomain
Characterisation of the Regulation and Dynamics of the RIG-I Signalling Network
Functional characterisation of PGAM5 in the WNT/β-catenin signalling pathway
Characterisation of complement signalling pathways that lead to prothrombotic cell activation
Subphenotype-based characterisation of signalling pathways in congenital heart defects (CHD)
Characterisation of a Recombinant Patchoulol Synthase Variant for Biocatalytic Production of Terpenes
Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling
Abiotic stress : screening and characterisation of signalling mutants
A secreted splice variant of the Xenopus frizzled-4 receptor is a biphasic modulator of Wnt signalling
Structural characterisation of the mammalian SRP receptor
Structural characterisation of peroxisomal import receptor complexes
Role of arylhydrocarbon receptor signalling in reactive gliosis
The signalling conformation of the insulin receptor ectodomain
Characterisation of the Regulation and Dynamics of the RIG-I Signalling Network
Functional characterisation of PGAM5 in the WNT/β-catenin signalling pathway
Characterisation of complement signalling pathways that lead to prothrombotic cell activation
Subphenotype-based characterisation of signalling pathways in congenital heart defects (CHD)
Characterisation of a Recombinant Patchoulol Synthase Variant for Biocatalytic Production of Terpenes
Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling
Abiotic stress : screening and characterisation of signalling mutants
A secreted splice variant of the Xenopus frizzled-4 receptor is a biphasic modulator of Wnt signalling
Structural characterisation of the mammalian SRP receptor
Structural characterisation of peroxisomal import receptor complexes
Role of arylhydrocarbon receptor signalling in reactive gliosis
The signalling conformation of the insulin receptor ectodomain
Characterisation of the Regulation and Dynamics of the RIG-I Signalling Network
Functional characterisation of PGAM5 in the WNT/β-catenin signalling pathway
Characterisation of complement signalling pathways that lead to prothrombotic cell activation
Subphenotype-based characterisation of signalling pathways in congenital heart defects (CHD)